About Fernando Aspiroz

Head of the Gastrointestinal Research Section at the Hospital General Vall d’Hebron in Barcelona, Spain, since 1987, he currently serves as Chair of the Gut Microbiota & Health section of the European Society of Neurogastroenterology and Motility. Prof. Aspiroz’s clinical practice takes place in a large referral unit and specifically focuses on functional gut disorders. His research programme investigates the origin of gastrointestinal symptoms and involves both physiological and pathophysiological aspects relating to the control mechanisms of gut motility, visceral sensitivity and more recently, intestinal gas dynamics.

"The human microbiota is a fundamental component of what it means to be human," says David Relman in a recent JAMA opinion piece. In this article, Relman gives a picture of the importance of the human microbiota in health and a brief history of how scientists have measured it.

Response To Drug May Be Dictated By The Microbiota

19 Jul 2013

by Fernando Aspiroz

The intestinal microbiota is known to modulate bioavailability and efficacy of endogenous compounds, nutrients or drugs, with large interindividual variations. The least conserved fraction of our microbiota may hence explain a stratification of the human population in converters and non